U.S. Smoking Cessation Drug Market

U.S. Smoking Cessation Drug Market published by Frost & Sullivan in December, 2007. This report consists of 85 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service covers the U.S. smoking cessation drug market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, product revenue forecasts, and market share analysis. The market is segmented by product: Zyban, Chantix, and emerging products. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

1 EXECUTIVE SUMMARY

• Executive Summary
  • Introduction

2 MARKET INTRODUCTION

• Research Scope and Methodology
  • Scope and Segmentation
  • Research Methodology
• Smoking Overview
  • Introduction
  • Smoking Statistics
  • Components of Cigarettes
  • Reasons To Quit Smoking
  • Health Risks of Smoking
  • Health Benefits from Quitting Smoking
  • Treatment Options
• Market Overview
  • Market Engineering Measurements
  • Industry Challenges
  • Market Drivers
  • Market Restraints

3 MARKET ANALYSIS

• Competitive Analysis
  • Competitive Structure
• Product Analysis
  • Zyban
  • Chantix
• Emerging Products
  • Emerging Smoking Cessation Drugs
  • Emerging Smoking Cessation Vaccines
• Patient Forecasts
  • Patient Forecasts
• Revenue Forecasts
  • Total Market Revenue Forecasts
  • Revenue Forecasts By Product
• Market Share Analysis
  • Company Market Share

4 APPENDIX

• Decision Support Databases
  • Incidence of Lung Cancer
  • Prevalence of Coronary Heart Disease
  • Total Cases of Stroke
  • Prevalence of COPD
  • Prevalence of Smokers

Related Reports